Write in a clean editor, then format for Drug Delivery in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Drug Delivery is a peer-reviewed journal published by Taylor & Francis, covering Advanced Drug Delivery Systems, Nanoparticle-Based Drug Delivery, Advancements in Transdermal Drug Delivery.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Drug Delivery 12 (3): 45–58.
Formats any DOI in Drug Delivery style. No sign-up. |
| Publishes research in | Advanced Drug Delivery Systems Nanoparticle-Based Drug Delivery Advancements in Transdermal Drug Delivery RNA Interference and Gene Delivery Drug Solubulity and Delivery Systems |
| ISSN | 1071-7544 |
| Citation impact (2-yr) | 5.16 |
| h-index | 131 |
| i10-index | 2,364 |
| Total citations | 119,819 |
| Article processing charge | $2,864 |
| Open access | Yes |
| Top institutions publishing here | Cairo University |
| Journal website | www.informahealthcare.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-associated system, Cas), and its repurposing into a potent gene editing tool has revolutionized the field of molecular biology and generated excitement…
Colloidal gold, a sol comprised of nanoparticles of Au(0), has been used as a therapeutic for the treatment of cancer as well as an indicator for immunodiagnostics. However, the use of these gold nanoparticles for in vivo drug delivery has never been described. This communication outlines the development of a colloidal gold (cAu) nanoparticle vector…
The protective function of human skin imposes physicochemical limitations to the type of permeant that can traverse the barrier. For a drug to be delivered passively via the skin it needs to have adequate lipophilicity and also a molecular weight <500 Da. These requirements have limited the number of commercially available products based on transdermal…
Many promising therapeutic agents are limited by their inability to reach the systemic circulation, due to the excellent barrier properties of biological membranes, such as the stratum corneum (SC) of the skin or the sclera/cornea of the eye and others. The outermost layer of the skin, the SC, is the principal barrier to topically-applied medications.…
Liposomes were the first nanoscale drug to be approved for clinical use in 1995. Since then, the technology has grown considerably, and pioneering recent work in liposome-based delivery systems has brought about remarkable developments with significant clinical implications. This includes long-circulating liposomes, stimuli-responsive liposomes, nebulized liposomes, elastic liposomes for topical, oral and transdermal delivery and…
